TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Indian Postpartum Care: A-randomised Trial to Improve Maternal Health Six Weeks After Birth
Brief Summary: After the child birth most women experience major health issues such as depression, severe fatigue, back pain, perineal pain, mastitis, urinary or faecal incontinence, sexual problems and relationship problems with partners. That all lead to poorer emotional and mental health and factors contributing isolation, exhaustion and physical health problems.

'Sava Mahina (6-week period) is a traditional practice for postpartum women in India, which include special diet, lifestyle and supportive care. The current multicenter randomized controlled trial (RCT) aims to evaluate outcomes of Indian postpartum care on women.


Options:
A: Arm Label: Cognitive Behavioral Therapy Intervention for Anxiety; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy Intervention for Anxiety | Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy Intervention for Anxiety; Assigned to Arm(s): Cognitive Behavioral Therapy Intervention for Anxiety
B: Arm Label: Accountable Condition- 8 clinics; Type: EXPERIMENTAL; Interventions: Behavioral: Accountable Condition | Arm Label: Control Condition- 8 clinics; Type: EXPERIMENTAL; Interventions: Behavioral: Control Condition | Intervention Type: BEHAVIORAL; Name: Accountable Condition; Assigned to Arm(s): Accountable Condition- 8 clinics | Intervention Type: BEHAVIORAL; Name: Control Condition; Assigned to Arm(s): Control Condition- 8 clinics
C: Arm Label: New breastfeeding programme; Type: EXPERIMENTAL; Interventions: Other: New Breastfeeding Counselling | Arm Label: Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment as usual | Intervention Type: OTHER; Name: New Breastfeeding Counselling; Assigned to Arm(s): New breastfeeding programme | Intervention Type: OTHER; Name: Treatment as usual; Assigned to Arm(s): Treatment as usual
D: Arm Label: Mother Touch Program; Type: EXPERIMENTAL; Interventions: Other: Mothers Touch Program | Arm Label: Usual care Program; Type: OTHER; Interventions: Other: Usual Care Program | Intervention Type: OTHER; Name: Mothers Touch Program; Assigned to Arm(s): Mother Touch Program | Intervention Type: OTHER; Name: Usual Care Program; Assigned to Arm(s): Usual care Program

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Indian Postpartum Care: A-randomised Trial to Improve Maternal Health Six Weeks After Birth
Brief Summary: After the child birth most women experience major health issues such as depression, severe fatigue, back pain, perineal pain, mastitis, urinary or faecal incontinence, sexual problems and relationship problems with partners. That all lead to poorer emotional and mental health and factors contributing isolation, exhaustion and physical health problems.

'Sava Mahina (6-week period) is a traditional practice for postpartum women in India, which include special diet, lifestyle and supportive care. The current multicenter randomized controlled trial (RCT) aims to evaluate outcomes of Indian postpartum care on women.


Options:
A: Arm Label: 3-week visit; Type: EXPERIMENTAL; Interventions: Other: 3-week visit | Arm Label: usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: usual care | Intervention Type: OTHER; Name: 3-week visit; Assigned to Arm(s): 3-week visit | Intervention Type: OTHER; Name: usual care; Assigned to Arm(s): usual care
B: Arm Label: Cognitive Behavioral Therapy Intervention for Anxiety; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy Intervention for Anxiety | Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy Intervention for Anxiety; Assigned to Arm(s): Cognitive Behavioral Therapy Intervention for Anxiety
C: Arm Label: Mother Touch Program; Type: EXPERIMENTAL; Interventions: Other: Mothers Touch Program | Arm Label: Usual care Program; Type: OTHER; Interventions: Other: Usual Care Program | Intervention Type: OTHER; Name: Mothers Touch Program; Assigned to Arm(s): Mother Touch Program | Intervention Type: OTHER; Name: Usual Care Program; Assigned to Arm(s): Usual care Program
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: RLPT | Intervention Type: BEHAVIORAL; Name: RLPT; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Effectiveness of Ischemic Pre-conditioning on the Morbidity and Mortality of Open Surgery of Thoracoabdominal Aortic Aneurysms.
Brief Summary: Patients having a planned open surgery of thoracoabdominal aortic aneurysms and enrolled in the study will be randomized the day of the surgery in 2 groups:

* Arm 1 : Patients with aortic clamping with pre-conditioning
* Arm 2 : Patients with aortic clamping without pre-conditioning Patients will be then followed, during 60 days after surgery.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Procedure: clamping with pre-conditioning (PCl) | Arm Label: Arm 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: clamping with pre-conditioning (PCl); Assigned to Arm(s): Arm 1
B: Arm Label: Remote ischaemic preconditioning; Type: EXPERIMENTAL; Interventions: Procedure: Remote ischaemic preconditioning | Arm Label: Control to RIPC; Type: SHAM_COMPARATOR; Interventions: Procedure: Control to RIPC | Intervention Type: PROCEDURE; Name: Remote ischaemic preconditioning; Assigned to Arm(s): Remote ischaemic preconditioning | Intervention Type: PROCEDURE; Name: Control to RIPC; Assigned to Arm(s): Control to RIPC
C: Arm Label: Sham; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Control | Arm Label: RIPC; Type: EXPERIMENTAL; Interventions: Procedure: Preconditioning | Intervention Type: PROCEDURE; Name: Preconditioning; Assigned to Arm(s): RIPC | Intervention Type: PROCEDURE; Name: Control; Assigned to Arm(s): Sham
D: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Remote ischaemic preconditioning | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Procedure: Control | Intervention Type: PROCEDURE; Name: Remote ischaemic preconditioning; Assigned to Arm(s): Intervention | Intervention Type: PROCEDURE; Name: Control; Assigned to Arm(s): Control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical Characterization of Burst Spinal Cord Stimulation for Chronic Pain Management
Brief Summary: Recently a new form of spinal cord stimulation therapy called burst spinal cord stimulation (Burst-SCS) is available to treat chronic pain. The goal of this study is to learn more about how Burst-SCS works to reduce chronic pain. The study will examine chronic pain patients who have been deemed candidates for Burst-SCS therapy, and who have already been selected to receive a temporary externalized trial of Burst-SCS from their own doctors as part of their standard clinical care for chronic pain management. During the study, participants will be asked to complete a variety of evaluations at certain time points. In addition, there will be a randomized, double blind, crossover phase, where the particular effects of Burst-SCS and sham SCS will be evaluated. The device used to deliver Burst-SCS and sham SCS is the St. Jude Medical Invisible Trial System.


Options:
A: Intervention Type: DEVICE; Name: Spinal Cord Stimulation; Assigned to Arm(s): N/A
B: Arm Label: SCS + OMM; Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal Cord Stimulation (SCS), Drug: Optimal Medical Management (OMM) | Arm Label: OMM alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Optimal Medical Management (OMM) | Intervention Type: DEVICE; Name: Spinal Cord Stimulation (SCS); Assigned to Arm(s): SCS + OMM | Intervention Type: DRUG; Name: Optimal Medical Management (OMM); Assigned to Arm(s): OMM alone, SCS + OMM
C: Arm Label: Burst-SCS/sham SCS; Type: OTHER; Interventions: Device: Burst-SCS, Device: Sham SCS | Arm Label: Sham SCS/Burst-SCS; Type: OTHER; Interventions: Device: Burst-SCS, Device: Sham SCS | Intervention Type: DEVICE; Name: Burst-SCS; Assigned to Arm(s): Burst-SCS/sham SCS, Sham SCS/Burst-SCS | Intervention Type: DEVICE; Name: Sham SCS; Assigned to Arm(s): Burst-SCS/sham SCS, Sham SCS/Burst-SCS
D: Arm Label: Spinal Cord Stimulation (SCS); Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal Cord Stimulation (SCS), Other: Physiotherapy | Arm Label: Physiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal Cord Stimulation (SCS), Other: Physiotherapy | Intervention Type: DEVICE; Name: Spinal Cord Stimulation (SCS); Assigned to Arm(s): Physiotherapy, Spinal Cord Stimulation (SCS) | Intervention Type: OTHER; Name: Physiotherapy; Assigned to Arm(s): Physiotherapy, Spinal Cord Stimulation (SCS)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical Characterization of Burst Spinal Cord Stimulation for Chronic Pain Management
Brief Summary: Recently a new form of spinal cord stimulation therapy called burst spinal cord stimulation (Burst-SCS) is available to treat chronic pain. The goal of this study is to learn more about how Burst-SCS works to reduce chronic pain. The study will examine chronic pain patients who have been deemed candidates for Burst-SCS therapy, and who have already been selected to receive a temporary externalized trial of Burst-SCS from their own doctors as part of their standard clinical care for chronic pain management. During the study, participants will be asked to complete a variety of evaluations at certain time points. In addition, there will be a randomized, double blind, crossover phase, where the particular effects of Burst-SCS and sham SCS will be evaluated. The device used to deliver Burst-SCS and sham SCS is the St. Jude Medical Invisible Trial System.


Options:
A: Arm Label: High Frequency; Type: EXPERIMENTAL; Interventions: Device: Spinal Cord Stimulator HF | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Spinal Cord Stimulator Sham | Intervention Type: DEVICE; Name: Spinal Cord Stimulator HF; Assigned to Arm(s): High Frequency | Intervention Type: DEVICE; Name: Spinal Cord Stimulator Sham; Assigned to Arm(s): Sham
B: Arm Label: Burst-SCS/sham SCS; Type: OTHER; Interventions: Device: Burst-SCS, Device: Sham SCS | Arm Label: Sham SCS/Burst-SCS; Type: OTHER; Interventions: Device: Burst-SCS, Device: Sham SCS | Intervention Type: DEVICE; Name: Burst-SCS; Assigned to Arm(s): Burst-SCS/sham SCS, Sham SCS/Burst-SCS | Intervention Type: DEVICE; Name: Sham SCS; Assigned to Arm(s): Burst-SCS/sham SCS, Sham SCS/Burst-SCS
C: Arm Label: Burst SCS; Type: ACTIVE_COMPARATOR; Interventions: Device: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10) | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10) | Intervention Type: DEVICE; Name: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10); Assigned to Arm(s): Burst SCS, Sham
D: Arm Label: Active Lead (AL); Type: ACTIVE_COMPARATOR; Interventions: Device: Nevro Senza System (HF10 Therapy) | Arm Label: Sham Lead (SL); Type: SHAM_COMPARATOR; Interventions: Device: Nevro Senza System (HF10 Therapy) | Intervention Type: DEVICE; Name: Nevro Senza System (HF10 Therapy); Assigned to Arm(s): Active Lead (AL), Sham Lead (SL)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical Characterization of Burst Spinal Cord Stimulation for Chronic Pain Management
Brief Summary: Recently a new form of spinal cord stimulation therapy called burst spinal cord stimulation (Burst-SCS) is available to treat chronic pain. The goal of this study is to learn more about how Burst-SCS works to reduce chronic pain. The study will examine chronic pain patients who have been deemed candidates for Burst-SCS therapy, and who have already been selected to receive a temporary externalized trial of Burst-SCS from their own doctors as part of their standard clinical care for chronic pain management. During the study, participants will be asked to complete a variety of evaluations at certain time points. In addition, there will be a randomized, double blind, crossover phase, where the particular effects of Burst-SCS and sham SCS will be evaluated. The device used to deliver Burst-SCS and sham SCS is the St. Jude Medical Invisible Trial System.


Options:
A: Arm Label: Spinal Cord Stimulation; Type: EXPERIMENTAL; Interventions: Device: WaveWriter | Arm Label: Conventional Medical Management; Type: OTHER; Interventions: Other: Conventional Medical Managament | Intervention Type: DEVICE; Name: WaveWriter; Assigned to Arm(s): Spinal Cord Stimulation | Intervention Type: OTHER; Name: Conventional Medical Managament; Assigned to Arm(s): Conventional Medical Management
B: Arm Label: Burst-SCS/sham SCS; Type: OTHER; Interventions: Device: Burst-SCS, Device: Sham SCS | Arm Label: Sham SCS/Burst-SCS; Type: OTHER; Interventions: Device: Burst-SCS, Device: Sham SCS | Intervention Type: DEVICE; Name: Burst-SCS; Assigned to Arm(s): Burst-SCS/sham SCS, Sham SCS/Burst-SCS | Intervention Type: DEVICE; Name: Sham SCS; Assigned to Arm(s): Burst-SCS/sham SCS, Sham SCS/Burst-SCS
C: Arm Label: scs high-frequency; Type: EXPERIMENTAL; Interventions: Device: Device: Precision Novi™ system Neurostimulation procedures | Arm Label: scs tonic; Type: EXPERIMENTAL; Interventions: Device: Device: Precision Novi™ system Neurostimulation procedures | Arm Label: scs burst; Type: EXPERIMENTAL; Interventions: Device: Device: Precision Novi™ system Neurostimulation procedures | Arm Label: scs off; Type: PLACEBO_COMPARATOR; Interventions: Device: Device: Precision Novi™ system Neurostimulation procedures | Intervention Type: DEVICE; Name: Device: Precision Novi™ system Neurostimulation procedures; Assigned to Arm(s): scs burst, scs high-frequency, scs off, scs tonic
D: Arm Label: Study sequence A; Type: EXPERIMENTAL; Interventions: Device: Proclaim™ Elite 5: Burst - Washout - Sham | Arm Label: Study sequence B; Type: EXPERIMENTAL; Interventions: Device: Proclaim™ Elite 5: Sham - Washout - Burst | Intervention Type: DEVICE; Name: Proclaim™ Elite 5: Burst - Washout - Sham; Assigned to Arm(s): Study sequence A | Intervention Type: DEVICE; Name: Proclaim™ Elite 5: Sham - Washout - Burst; Assigned to Arm(s): Study sequence B

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Sleep and Appetite Measures as Suicidal Risk Factors in a French- Spanish Cohort of Suicidal Patients.
Brief Summary: Sleep and appetite disorders as well as social exclusion, have been linked to the emergence of suicidal ideation (SI) and suicide attempts.This study aims to evaluate the relationship between those factors and suicidal ideation and behaviour. To assess those factors an ecological momentary assessment (EMA) desing will be used.

EMA will be carried out using 2 applications integrated into the smartphone of participants (Android or iOS), one to make an explicit data collection with questions and another one for the implicit collection of data from mobile sensors.

1044 suicide attempters will be included in three sites and followed for 6 months. Participants will be evaluated at inclusion and at the end of follow-up. The hypothesis is that sleep, appetite and social exclusion factors collected with the smartphone application will be linked to the intensity of death wish, suicidal ideations and suicidal attempts.

An auxiliary study will also be led with 300 patients carrying an actimeter for the 30 first days after inclusion. This will help collecting more accurate data on various sleep parameters.


Options:
A: Arm Label: Brief Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Brief Intervention for Suicidality | Arm Label: care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Brief Intervention for Suicidality; Assigned to Arm(s): Brief Intervention
B: Arm Label: Study participants; Type: EXPERIMENTAL; Interventions: Other: EMA | Intervention Type: OTHER; Name: EMA; Assigned to Arm(s): Study participants
C: Arm Label: meditation; Type: EXPERIMENTAL; Interventions: Behavioral: Central Meditation and Imagery Therapy | Arm Label: wait list; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Central Meditation and Imagery Therapy; Assigned to Arm(s): meditation
D: Arm Label: PS CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Problem solving cognitive behaviour therapy (PS CBT) | Arm Label: Treatment as Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Problem solving cognitive behaviour therapy (PS CBT); Assigned to Arm(s): PS CBT

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Sleep and Appetite Measures as Suicidal Risk Factors in a French- Spanish Cohort of Suicidal Patients.
Brief Summary: Sleep and appetite disorders as well as social exclusion, have been linked to the emergence of suicidal ideation (SI) and suicide attempts.This study aims to evaluate the relationship between those factors and suicidal ideation and behaviour. To assess those factors an ecological momentary assessment (EMA) desing will be used.

EMA will be carried out using 2 applications integrated into the smartphone of participants (Android or iOS), one to make an explicit data collection with questions and another one for the implicit collection of data from mobile sensors.

1044 suicide attempters will be included in three sites and followed for 6 months. Participants will be evaluated at inclusion and at the end of follow-up. The hypothesis is that sleep, appetite and social exclusion factors collected with the smartphone application will be linked to the intensity of death wish, suicidal ideations and suicidal attempts.

An auxiliary study will also be led with 300 patients carrying an actimeter for the 30 first days after inclusion. This will help collecting more accurate data on various sleep parameters.


Options:
A: Arm Label: Iconic Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Emotional regulation | Arm Label: Support therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Emotional regulation | Intervention Type: BEHAVIORAL; Name: Emotional regulation; Assigned to Arm(s): Iconic Therapy, Support therapy
B: Arm Label: Study participants; Type: EXPERIMENTAL; Interventions: Other: EMA | Intervention Type: OTHER; Name: EMA; Assigned to Arm(s): Study participants
C: Arm Label: Inpatient Adaptation of DBT; Type: EXPERIMENTAL; Interventions: Behavioral: Inpatient Adaptation of DBT | Arm Label: Outpatient DBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: standard outpatient DBT | Intervention Type: BEHAVIORAL; Name: standard outpatient DBT; Assigned to Arm(s): Outpatient DBT | Intervention Type: BEHAVIORAL; Name: Inpatient Adaptation of DBT; Assigned to Arm(s): Inpatient Adaptation of DBT
D: Arm Label: active anodal tDCS to ventrolateral prefrontal cortex (VLPFC); Type: ACTIVE_COMPARATOR; Interventions: Device: Transcranial direct current stimulation | Arm Label: sham anodal tDCS to VLPFC; Type: SHAM_COMPARATOR; Interventions: Device: Transcranial direct current stimulation | Arm Label: Discontinued prior to randomization; Type: OTHER; Interventions: Other: No intervention | Intervention Type: DEVICE; Name: Transcranial direct current stimulation; Assigned to Arm(s): active anodal tDCS to ventrolateral prefrontal cortex (VLPFC), sham anodal tDCS to VLPFC | Intervention Type: OTHER; Name: No intervention; Assigned to Arm(s): Discontinued prior to randomization

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Sleep and Appetite Measures as Suicidal Risk Factors in a French- Spanish Cohort of Suicidal Patients.
Brief Summary: Sleep and appetite disorders as well as social exclusion, have been linked to the emergence of suicidal ideation (SI) and suicide attempts.This study aims to evaluate the relationship between those factors and suicidal ideation and behaviour. To assess those factors an ecological momentary assessment (EMA) desing will be used.

EMA will be carried out using 2 applications integrated into the smartphone of participants (Android or iOS), one to make an explicit data collection with questions and another one for the implicit collection of data from mobile sensors.

1044 suicide attempters will be included in three sites and followed for 6 months. Participants will be evaluated at inclusion and at the end of follow-up. The hypothesis is that sleep, appetite and social exclusion factors collected with the smartphone application will be linked to the intensity of death wish, suicidal ideations and suicidal attempts.

An auxiliary study will also be led with 300 patients carrying an actimeter for the 30 first days after inclusion. This will help collecting more accurate data on various sleep parameters.


Options:
A: Arm Label: Study participants; Type: EXPERIMENTAL; Interventions: Other: EMA | Intervention Type: OTHER; Name: EMA; Assigned to Arm(s): Study participants
B: Arm Label: Control (volitional help sheet); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Volitional help sheet | Arm Label: Intervention (volitional help sheet); Type: EXPERIMENTAL; Interventions: Behavioral: Volitional help sheet | Intervention Type: BEHAVIORAL; Name: Volitional help sheet; Assigned to Arm(s): Control (volitional help sheet) | Intervention Type: BEHAVIORAL; Name: Volitional help sheet; Assigned to Arm(s): Intervention (volitional help sheet)
C: Arm Label: Prevention Program; Type: EXPERIMENTAL; Interventions: Behavioral: Prevention program | Arm Label: Assessment Only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Prevention program; Assigned to Arm(s): Prevention Program
D: Arm Label: Brief Cognitive Behavioral Therapy (BCBT); Type: EXPERIMENTAL; Interventions: Behavioral: Brief Cognitive Behavioral Therapy (BCBT) | Arm Label: Treatment As Usual (TAU); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment As Usual (TAU) | Intervention Type: BEHAVIORAL; Name: Brief Cognitive Behavioral Therapy (BCBT); Assigned to Arm(s): Brief Cognitive Behavioral Therapy (BCBT) | Intervention Type: BEHAVIORAL; Name: Treatment As Usual (TAU); Assigned to Arm(s): Treatment As Usual (TAU)

Answer: A